Support and Resistance Levels
Past performance
About Bafna Pharmaceuticals Ltd Bafna Pharmaceuticals Limited, established in 1981 by Mr. Bafna Mahaveer Chand, specializes in manufacturing pharmaceutical formulations including Betalactum and Non Betalactum products. The company, initially a proprietary concern, transitioned into a corporate entity in 1995, acquiring its entire business and expanding its production capabilities. Bafna has gained recognition in several international markets, with products registered in countries such as Sri Lanka, Ghana, and Ukraine. An Export House status was granted by the Government of India in 2003, and Bafna was awarded the Best Supplier by the Sri Lankan Government in 2005.
The company has progressively moved into regulated European markets, establishing a state-of-the-art manufacturing unit in Chennai in 2006, adhering to European GMP standards. Bafna's strategic partnerships, such as with UK's Somex Pharma, and its recent expansions with UK-MHRA and TGA-Australia accreditations, underscore its commitment to quality and growth in both regulated and emerging markets.